General Biotechnology

It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving […]

It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving

Long Trip for Psychedelic Drugs “Psychedelic drugs are inching their way slowly but surely toward prescription status in the United

Genetically altered grass spreads like wildfire “A new study shows that genes from genetically engineered grass can spread much farther

How Dublin Keeps Big Pharma Happy “It’s moving from basic manufacturing to sophisticated R&D to fend off rivals”

The Trials of ImClone “A founder in handcuffs, financials in disarray, and a vital product in doubt-for CEO Daniel Lynch,

The Time Is Right for These Seven Biotechs “In most years, biotechs decline in the spring as investors anticipate a

Biotech Knockoffs Lure Novartis “A big pharma player is expanding its generics business. Expect others to follow The divide between

Biotech returning to favor “After a nearly four-year slowdown, money is beginning to flow again into the biotechnology sector. But

Drug firms in United States, Europe move biotech work to India “Drug makers in the United States and Europe are